Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. 2017

Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee.

The potential impact of using human genetic data linked to longitudinal electronic medical records on drug development is extraordinary; however, the practical application of these data necessitates some organizational innovations. Vanderbilt has created resources such as an easily queried database of >2.6 million de-identified electronic health records linked to BioVU, which is a DNA biobank with more than 230,000 unique samples. To ensure these data are used to maximally benefit and accelerate both de novo drug discovery and drug repurposing efforts, we created the Accelerating Drug Development and Repurposing Incubator, a multidisciplinary think tank of experts in various therapeutic areas within both basic and clinical science as well as experts in legal, business, and other operational domains. The Incubator supports a diverse pipeline of drug indication finding projects, leveraging the natural experiment of human genetics.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071185 Pharmacogenomic Testing The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS. Pharmacogenetic Analysis,Pharmacogenetic Screening,Pharmacogenetic Study,Pharmacogenetic Testing,Pharmacogenomic Analysis,Pharmacogenomic Screening,Pharmacogenomic Study,Pharmacogenetic Analyses,Pharmacogenetic Screenings,Pharmacogenetic Studies,Pharmacogenetic Testings,Pharmacogenomic Analyses,Pharmacogenomic Screenings,Pharmacogenomic Studies,Pharmacogenomic Testings,Studies, Pharmacogenetic
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015894 Genome, Human The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs. Human Genome,Genomes, Human,Human Genomes
D057285 Precision Medicine Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile. Individualized Medicine,Predictive Medicine,P Health,P-Health,Personalized Medicine,Theranostics,Medicine, Individualized,Medicine, Personalized,Medicine, Precision,Medicine, Predictive,Theranostic
D058492 Drug Repositioning The deliberate and methodical practice of finding new applications for existing drugs. Drug Repurposing,Drug Rescue,Repositioning, Drug,Repurposing, Drug,Rescue, Drug
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic
D030541 Databases, Genetic Databases devoted to knowledge about specific genes and gene products. Genetic Databases,Genetic Sequence Databases,OMIM,Online Mendelian Inheritance In Man,Genetic Data Banks,Genetic Data Bases,Genetic Databanks,Genetic Information Databases,Bank, Genetic Data,Banks, Genetic Data,Data Bank, Genetic,Data Banks, Genetic,Data Base, Genetic,Data Bases, Genetic,Databank, Genetic,Databanks, Genetic,Database, Genetic,Database, Genetic Information,Database, Genetic Sequence,Databases, Genetic Information,Databases, Genetic Sequence,Genetic Data Bank,Genetic Data Base,Genetic Databank,Genetic Database,Genetic Information Database,Genetic Sequence Database,Information Database, Genetic,Information Databases, Genetic,Sequence Database, Genetic,Sequence Databases, Genetic

Related Publications

Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
December 2018, JCO clinical cancer informatics,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
November 2022, Life sciences in space research,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
July 2017, Trends in cardiovascular medicine,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
August 2023, Addiction biology,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
April 2020, Current opinion in pharmacology,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
July 2022, Cancer discovery,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
March 2019, The New England journal of medicine,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
January 2021, Advances in experimental medicine and biology,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
January 2016, Public health genomics,
Jill M Pulley, and Jana K Shirey-Rice, and Robert R Lavieri, and Rebecca N Jerome, and Nicole M Zaleski, and David M Aronoff, and Lisa Bastarache, and Xinnan Niu, and Kenneth J Holroyd, and Dan M Roden, and Eric P Skaar, and Colleen M Niswender, and Lawrence J Marnett, and Craig W Lindsley, and Leeland B Ekstrom, and Alan R Bentley, and Gordon R Bernard, and Charles C Hong, and Joshua C Denny
July 2021, Cancers,
Copied contents to your clipboard!